Remission of idiopathic retroperitoneal fibrosis by ofatumumab as a disease-modifying therapy for multiple sclerosis
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
eNeurologicalSci - 29(2022) vom: 28. Dez., Seite 100428 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hanazono, Akira [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Dimethyl fumarate |
|---|
| Anmerkungen: |
Date Revised 06.10.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.ensci.2022.100428 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM347089070 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM347089070 | ||
| 003 | DE-627 | ||
| 005 | 20231226033009.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ensci.2022.100428 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1156.xml |
| 035 | |a (DE-627)NLM347089070 | ||
| 035 | |a (NLM)36193452 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hanazono, Akira |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Remission of idiopathic retroperitoneal fibrosis by ofatumumab as a disease-modifying therapy for multiple sclerosis |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 06.10.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Dimethyl fumarate | |
| 650 | 4 | |a IgG4-related disease | |
| 650 | 4 | |a Interferon β1b | |
| 650 | 4 | |a Rituximab | |
| 700 | 1 | |a Sanpei, Yui |e verfasserin |4 aut | |
| 700 | 1 | |a Shimada, Hinako |e verfasserin |4 aut | |
| 700 | 1 | |a Yasuda, Keita |e verfasserin |4 aut | |
| 700 | 1 | |a Takahashi, Yoshiko |e verfasserin |4 aut | |
| 700 | 1 | |a Funasaka, Homare |e verfasserin |4 aut | |
| 700 | 1 | |a Sagehashi, Ryuichiro |e verfasserin |4 aut | |
| 700 | 1 | |a Hiroshima, Yuko |e verfasserin |4 aut | |
| 700 | 1 | |a Nanjo, Hiroshi |e verfasserin |4 aut | |
| 700 | 1 | |a Sugawara, Masashiro |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t eNeurologicalSci |d 2015 |g 29(2022) vom: 28. Dez., Seite 100428 |w (DE-627)NLM252720156 |x 2405-6502 |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2022 |g day:28 |g month:12 |g pages:100428 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ensci.2022.100428 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2022 |b 28 |c 12 |h 100428 | ||